Generic Portal

Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancer

ten Hoorn, S., Waasdorp, C., van Oijen, M. G. H., Damhofer, H., Trinh, A., Zhao, L., Smits, L. J. H., Bootsma, S., van Pelt, G. W., Mesker, W. E., Mol, L., Goey, K. K. H., Koopman, M., Medema, J. P., Tuynman, J. B., Zlobec, I., Punt, C. J. A., Vermeulen, L. & Bijlsma, M. F., 1 Dec 2022, In: BMC cancer. 22, 1, 394.

Research output: Contribution to journal › Article › Academic › peer-review

Unsupervised class discovery in pancreatic ductal adenocarcinoma reveals cell-intrinsic mesenchymal features and high concordance between existing classification systems

Dijk, F., Veenstra, V. L., Soer, E. C., Dings, M. P. G., Zhao, L., Halfwerk, J. B., Hooijer, G. K., Damhofer, H., Marzano, M., Steins, A., Waasdorp, C., Busch, O. R., Besselink, M. G., Tol, J. A., Welling, L., van Rijssen, L. B., Klompmaker, S., Wilmink, H. W., van Laarhoven, H. W., Medema, J. P., & 7 othersVermeulen, L., van Hooff, S. R., Koster, J., Verheij, J., van de Vijver, M. J., Wang, X. & Bijlsma, M. F., 1 Dec 2020, In: Scientific reports. 10, 1, p. 337 337.

Research output: Contribution to journal › Article › Academic › peer-review

ADAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapy

Veenstra, V. L., Damhofer, H., Waasdorp, C., van Rijssen, L. B., van de Vijver, M. J., Dijk, F., Wilmink, H. W., Besselink, M. G., Busch, O. R., Chang, D. K., Bailey, P. J., Biankin, A. V., Kocher, H. M., Medema, J. P., Li, J. S., Jiang, R., Pierce, D. W., van Laarhoven, H. W. M. & Bijlsma, M. F., 2018, In: Oncogenesis. 7, 11, 87.

Research output: Contribution to journal › Article › Academic › peer-review

Patched-2 functions to limit Patched-1 deficient skin cancer growth

Veenstra, V. L., Dingjan, I., Waasdorp, C., Damhofer, H., van der Wal, A. C., van Laarhoven, H. W., Medema, J. P. & Bijlsma, M. F., 2018, In: Cellular oncology. 41, 4, p. 427-437

Research output: Contribution to journal › Article › Academic › peer-review

Dabigatran Potentiates Gemcitabine-Induced Growth Inhibition of Pancreatic Cancer in Mice

Shi, K., Damhofer, H., Daalhuisen, J., ten Brink, M., Richel, D. J. & Spek, C. A., 2017, In: Molecular medicine (Cambridge, Mass.). 23, p. 13-23

Research output: Contribution to journal › Article › Academic › peer-review

Stromal SPOCK1 supports invasive pancreatic cancer growth

Veenstra, V. L., Damhofer, H., Waasdorp, C., Steins, A., Kocher, H. M., Medema, J. P., van Laarhoven, H. W. & Bijlsma, M. F., 2017, In: Molecular oncology. 11, 8, p. 1050-1064

Research output: Contribution to journal › Article › Academic › peer-review

ADAM10-mediated release of heregulin confers resistance to trastuzumab by activating HER3

Ebbing, E. A., Medema, J. P., Damhofer, H., Meijer, S. L., Krishnadath, K. K., van Berge Henegouwen, M. I., Bijlsma, M. F. & van Laarhoven, H. W. M., 2016, In: Oncotarget. 7, 9, p. 10243-10254

Research output: Contribution to journal › Article › Academic › peer-review

Blocking Hedgehog release from pancreatic cancer cells increases paracrine signaling potency

Damhofer, H., Veenstra, V. L., Tol, J. A. M. G., van Laarhoven, H. W. M., Medema, J. P. & Bijlsma, M. F., 2015, In: Journal of cell science. 128, 1, p. 129-139

Research output: Contribution to journal › Article › Academic › peer-review

Establishment of patient-derived xenograft models and cell lines for malignancies of the upper gastrointestinal tract

Damhofer, H., Ebbing, E. A., Steins, A., Welling, L., Tol, J. A., Krishnadath, K. K., van Leusden, T., van de Vijver, M. J., Besselink, M. G., Busch, O. R., van Berge Henegouwen, M. I., van Delden, O., Meijer, S. L., Dijk, F., Medema, J. P., van Laarhoven, H. W. & Bijlsma, M. F., 2015, In: Journal of translational medicine. 13, 1, p. 115

Research output: Contribution to journal › Article › Academic › peer-review